Abstract
Marine polymers are a great group of macromolecules of interest for biomedical applications due to their biocompatibility, nontoxicity, and physical, chemical, structural, and pharmacological features. There are two possibilities to apply them for central nervous system (CNS) diseases: (a) as active substances (some marine polymers has biological activity per se and can be explored due to their pharmacological properties for diseases treatments) and (b) as materials (other marine polymers are excellent candidates as nano- or micro-vehicles to encapsulate drugs in order to overcome blood-brain barrier (BBB) access limitations or even target a specific area in the CNS). In this chapter, a brief anatomical/physiological review of the central nervous system and the blood-brain barrier, as well as the main drug access routes and limitations to target injured areas, will be carried out. The most common pathologies will be addressed with an emphasis on the therapeutic target of each of them, and the current applications described of marine polymers for central nervous system pathologies will be reviewed. The study revealed that marine polymers have a great potential for their application in CNS formulations and that a lot of research in this field is required to explore all the potential of these aquatic substances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aam BB, Heggset EB, Norberg AL et al (2010) Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs 8:1482–1517
Abbot NJ, Patabendige AAK, Dolman DEM et al (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37:13–25
Abdallah MM, Fernández N, Matias AA, Bronze MR (2020) Hyaluronic acid and Chondroitin sulfate from marine and terrestrial sources: extraction and purification methods. Carbohydr Polym 243:116441
Abhilash M, Thomas D (2017) Biopolymers for biocomposites and chemical sensor applications. In: Biopolymer composites in electronics. Elsevier Inc, Philadelphia, PA, pp 405–435
Aghoghovwia B, Mytilinaios D (2020) Meninges of the brain and spinal cord: anatomy, function | Kenhub. https://www.kenhub.com/en/library/anatomy/meninges-of-the-brain-and-spinal-cord. Accessed 25 Jun 2020
Ahmad N, Ahmad R, Alrasheed RA et al (2020a) Quantification and evaluations of catechin hydrate polymeric nanoparticles used in brain targeting for the treatment of epilepsy. Pharmaceutics 12:203. https://doi.org/10.3390/pharmaceutics12030203
Ahmad SI, Ahmad R, Khan MS et al (2020b) Chitin and its derivatives: structural properties and biomedical applications. Int J Biol Macromol 164:526–539
Ahn JH, Shin MC, Kim DW et al (2019) Antioxidant properties of fucoidan alleviate acceleration and exacerbation of hippocampal neuronal death following transient global cerebral ischemia in high-fat diet-induced obese gerbils. Int J Mol Sci 20:554
Almond A (2007) Hyaluronan. Cell Mol Life Sci 64:1591–1596
Alves A, Sousa RA, Reis RL (2013) A practical perspective on ulvan extracted from green algae. J Appl Phycol 25:407–424
American Association of Neurological Surgeons Glioblastoma Multiforme (n.d.). https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Glioblastoma-Multiforme. Accessed 5 Aug 2020
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5). American Psychiatric Association, Washington, DC. Fifth. Reviews
American Stroke Association (2018) What is a TIA. https://www.stroke.org/en/about-stroke/types-of-stroke/tia-transient-ischemic-attack/what-is-a-tia. Accessed 4 Aug 2020
An H, Li Q, Wen J (2020) Bone marrow mesenchymal stem cells encapsulated thermal-responsive hydrogel network bridges combined photo-plasmonic nanoparticulate system for the treatment of urinary bladder dysfunction after spinal cord injury. J Photochem Photobiol B Biol 203:111741. https://doi.org/10.1016/j.jphotobiol.2019.111741
Azeem M, Batool F, Iqbal N, Ikram-ul-Haq (2017) Algal-based biopolymers. In: Algae based polymers, blends, and composites: chemistry, biotechnology and materials science. Elsevier, Amsterdam, pp 1–31
Barbosa AI, Coutinho AJ, Costa Lima SA, Reis S (2019) Marine polysaccharides in pharmaceutical applications: fucoidan and chitosan as key players in the drug delivery match field. Mar Drugs 17:654
Bardajee GR, Khamooshi N, Nasri S, Vancaeyzeele C (2020) Multi-stimuli responsive nanogel/hydrogel nanocomposites based on κ-carrageenan for prolonged release of levodopa as model drug. Int J Biol Macromol 153:180–189
Beghi E (2020) The epidemiology of epilepsy. Neuroepidemiology 54:185–191
Blasco-Serra A, González-Soler EM, Cervera-Ferri A et al (2017) A standardization of the novelty-suppressed feeding test protocol in rats. Neurosci Lett 658:73–78
Blaško J, Szekiova E, Slovinska L et al (2017) Axonal outgrowth stimulation after alginate/mesenchymal stem cell therapy in injured rat spinal cord. Acta Neurobiol Exp 77:337–350
Caban-Toktas S, Sahin A, Lule S et al (2020) Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. Int J Pharm 578:119076
Can A, Dao DT, Arad M et al (2011a) The mouse forced swim test. J Vis Exp (59):3638. https://doi.org/10.3791/3638
Can A, Dao DT, Terrillion CE et al (2011b) The tail suspension test. J Vis Exp (59):3769. https://doi.org/10.3791/3769
Cardia MC, Carta AR, Caboni P et al (2019) Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders. Pharmaceutics 11:657. https://doi.org/10.3390/pharmaceutics11120657
ChEBI Agarose (n.d.) (CHEBI:2511) https://www.ebi.ac.uk/chebi/searchId.do?chebiId=2511. Accessed 14 Aug 2020
Cometa S, Bonifacio MA, Trapani G et al (2020) In vitro investigations on dopamine loaded solid lipid nanoparticles. J Pharm Biomed Anal 185:113257. https://doi.org/10.1016/j.jpba.2020.113257
Crumbie L, Johnson E (2020) Diencephalon: anatomy and function | Kenhub. https://www.kenhub.com/en/library/anatomy/diencephalon. Accessed 20 Jun 2020
CyberColloids (n.d.) Introduction to carrageenan - structure. http://www.cybercolloids.net/information/technical-articles/introduction-carrageenan-structure. Accessed 14 Aug 2020
Delattre C, Fenoradosoa TA, Michaud P (2011) Galactans: an overview of their most important sourcing and applications as natural polysaccharides. Braz Arch Biol Technol 54:1075–1092
Dimitrova-Shumkovska J, Krstanoski L, Veenman L (2020) Potential beneficial actions of fucoidan in brain and liver injury, disease, and intoxication-potential implication of sirtuins. Mar Drugs 18:242. https://doi.org/10.3390/md18050242
Encyclopædia Britannica (2019) Epilepsy. https://www.britannica.com/science/epilepsy. Accessed 29 Jul 2020
Eom TK, Ryu BM, Lee JK et al (2013) β-secretase inhibitory activity of phenolic acid conjugated chitooligosaccharides. J Enzyme Inhib Med Chem 28:214–217
Gabathuler R (2010) Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 37:48–57
Garre-Olmo J (2018) Epidemiology of Alzheimer’s disease and other dementias. Rev Neurol 66:377–386
Gascon S, Solano AG, El Kheir W et al (2020) Characterization and mathematical modeling of alginate/chitosan-based nanoparticles releasing the chemokine cxcl12 to attract glioblastoma cells. Pharmaceutics 12:356
Geng L, Wang J, Zhang Z et al (2019) Structure and bioactivities of porphyrans and oligoporphyrans. Curr Pharm Des 25:1163–1171
Gonçalves VSS, Matias AA, Poejo J et al (2016) Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs. Int J Pharm 515:1–10
Ham TR, Pukale DD, Hamrangsekachaee M, Leipzig ND (2020) Subcutaneous priming of protein-functionalized chitosan scaffolds improves function following spinal cord injury. Mater Sci Eng C Mater Biol Appl 110:110656. https://doi.org/10.1016/j.msec.2020.110656
Hervé F, Ghinea N, Scherrmann JM (2008) CNS delivery via adsorptive transcytosis. AAPS J 10:455–472
Huff T, Varacallo M (2019) Neuroanatomy, cerebrospinal fluid. StatPearls Publishing, Treasure Island, FL
Huntington’s Disease Society of America (2020) Overview of Huntington’s disease. https://hdsa.org/what-is-hd/overview-of-huntingtons-disease/. Accessed 4 Aug 2020
Islam S, Bhuiyan MAR, Islam MN (2017) Chitin and chitosan: structure, properties and applications in biomedical engineering. J Polym Environ 25:854–866
de Jesus RM, de Morais A, de Morais R (2015) Marine polysaccharides from algae with potential biomedical applications. Mar Drugs 13:2967–3028
Johnson W, Onuma O, Owolabi M, Sachdev S (2016) Stroke: a global response is needed. World Health Organization, Geneva
Khan NU, Miao T, Ju X et al (2019) Carrier-mediated transportation through BBB. In: Brain targeted drug delivery system. Elsevier, Amsterdam, pp 129–158
Kidgell JT, Magnusson M, de Nys R, Glasson CRK (2019) Ulvan: a systematic review of extraction, composition and function. Algal Res 39:101422
Komada M, Takao K, Miyakawa T (2008) Elevated plus maze for mice. J Vis Exp (22):1088. https://doi.org/10.3791/1088
Kuo YC, Wang LJ, Rajesh R (2019) Targeting human brain cancer stem cells by curcumin-loaded nanoparticles grafted with anti-aldehyde dehydrogenase and sialic acid: colocalization of ALDH and CD44. Mater Sci Eng C 102:362–372
Laurienzo P (2010) Marine polysaccharides in pharmaceutical applications: an overview. Mar Drugs 8:2435–2465
Lee SH, Park JS, Kim SK et al (2009) Chitooligosaccharides suppress the level of protein expression and acetylcholinesterase activity induced by Aβ25-35 in PC12 cells. Bioorg Med Chem Lett 19:860–862
Lee TK, Ahn JH, Park CW et al (2020) Pre-treatment with laminarin protects hippocampal CA1 pyramidal neurons and attenuates reactive gliosis following transient forebrain ischemia in gerbils. Mar Drugs 18:52. https://doi.org/10.3390/md18010052
Li M, Sun X, Li Q et al (2020) Fucoidan exerts antidepressant-like effects in mice via regulating the stability of surface AMPARs. Biochem Biophys Res Commun 521:318–325
Liao CH, Lai IC, Kuo HC et al (2019) Epigenetic modification and differentiation induction of malignant glioma cells by oligo-fucoidan. Mar Drugs 17:525. https://doi.org/10.3390/md17090525
Liu Y, Jiang L, Li X (2017) κ-carrageenan-derived pentasaccharide attenuates Aβ25-35-induced apoptosis in SH-SY5Y cells via suppression of the JNK signaling pathway. Mol Med Rep 15:285–290
Liu Y, Geng L, Zhang J et al (2018) Oligo-porphyran ameliorates neurobehavioral deficits in parkinsonian mice by regulating the PI3K/Akt/Bcl-2 pathway. Mar Drugs 16:82. https://doi.org/10.3390/md16030082
Living Cell Technologies Limited (2020) NTCELL. https://lctglobal.com/research/ntcell. Accessed 10 Aug 2020
Löscher W, Potschka H (2005) Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:86–98
Lu CT, Zhao YZ, Wong HL et al (2014) Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine 9:2241–2257
Mamo JC, Lam V, Al-Salami H et al (2018) Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration. Ther Deliv 9:703–709
Mayfield Brain & Spine (2018) Anatomy of the human brain. https://mayfieldclinic.com/pe-anatbrain.htm. Accessed 11 Jun 2020
Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:22–34
Mišurcová L, Škrovánková S, Samek D et al (2012) Health benefits of algal polysaccharides in human nutrition. In: Advances in food and nutrition research. Academic Press Inc, London, pp 75–145
Moghaddam AH, Mokhtari Sangdehi SR, Ranjbar M, Hasantabar V (2020) Preventive effect of silymarin-loaded chitosan nanoparticles against global cerebral ischemia/reperfusion injury in rats. Eur J Pharmacol 877:173066. https://doi.org/10.1016/j.ejphar.2020.173066
Morrice LM, McLean MW, Long WF, Williamson FB (1984) Porphyran primary structure. In: Eleventh International Seaweed Symposium. Springer, Dordrecht, pp 572–575
Moussian B (2019) Chitin: structure, chemistry and biology. In: Advances in experimental medicine and biology. Springer, New York, NY, pp 5–18
Mulroney SE, Myers AK (2011) 4. Organization and general functions of the nervous system. In: Netter’s essential physiology, 1st edn. Elsevier Inc, Amsterdam, pp 49–58
National Institute of Child Health and Human Development (2016) What are the treatments for spinal cord injury (SCI)? https://www.nichd.nih.gov/health/topics/spinalinjury/conditioninfo/treatments. Accessed 4 Aug 2020
National Institute of Child Health and Human Development (2019) Medication treatment for autism. https://www.nichd.nih.gov/health/topics/autism/conditioninfo/treatments/medication-treatment. Accessed 27 Jul 2020
National Institute of Neurological Disorders and Stroke (2013) Amyotrophic lateral sclerosis (ALS) fact sheet. https://www.ninds.nih.gov/disorders/Patient-Caregiver-Education/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet. Accessed 4 Aug 2020
National Institute on Aging (2017) Parkinson’s disease. https://www.nia.nih.gov/health/parkinsons-disease. Accessed 4 Aug 2020
National Institute on Aging (2019) Alzheimer’s disease fact sheet. https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet. Accessed 2 Aug 2020
Nazemi Z, Nourbakhsh MS, Kiani S et al (2020) Co-delivery of minocycline and paclitaxel from injectable hydrogel for treatment of spinal cord injury. J Control Release 321:145–158
Nguyen TPT, Tran BM, Lee NY (2018) Microfluidic approach for the fabrication of cell-laden hollow fibers for endothelial barrier research. J Mater Chem B 6:6057–6066
NHS (2018) Alzheimer’s disease. https://www.nhs.uk/conditions/alzheimers-disease/. Accessed 2 Aug 2020
NHS (2019a) Migraine. https://www.nhs.uk/conditions/migraine/. Accessed 29 Jul 2020
NHS (2019b) Stroke. https://www.nhs.uk/conditions/stroke/. Accessed 4 Aug 2020
Ojeda-Hernández DD, Canales-Aguirre AA, Matias-Guiu J et al (2020) Potential of chitosan and its derivatives for biomedical applications in the central nervous system. Front Bioeng Biotechnol 8:389. https://doi.org/10.3389/fbioe.2020.00389
OpenStax College (n.d.) The central nervous system. Anatomy and physiology. https://courses.lumenlearning.com/nemcc-ap/chapter/the-central-nervous-system/. Accessed 11 Jun 2020
Osama M, Nasr Mostafa M, Ali Alvi M (2020) Astrocyte elevated gene-1 as a novel therapeutic target in malignant gliomas and its interactions with oncogenes and tumor suppressor genes. Brain Res 2020:147034. https://doi.org/10.1016/j.brainres.2020.147034
Pangestuti R, Kim SK (2014) Biological activities of carrageenan. In: Advances in food and nutrition research. Academic Press Inc, New York, NY, pp 113–124
Park SK, Kang JY, Kim JM et al (2019) Fucoidan-rich substances from ecklonia cava improve trimethyltin-induced cognitive dysfunction via down-regulation of amyloid β production/tau hyperphosphorylation. Mar Drugs 17:591. https://doi.org/10.3390/md17100591
Park JH, Ahn JH, Lee TK et al (2020) Laminarin pretreatment provides neuroprotection against forebrain ischemia/reperfusion injury by reducing oxidative stress and neuroinflammation in aged gerbils. Mar Drugs 18:213. https://doi.org/10.3390/md18040213
Parkinson’s Foundation (2020) Understanding Parkinson’s: statistics. https://www.parkinson.org/Understanding-Parkinsons/Statistics. Accessed 4 Aug 2020
Pinhassi RI, Assaraf YG, Farber S et al (2010) Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells. Biomacromolecules 11:294–303
PubChem (n.d.) Chondroitin sulfate. C13H21NO15S. https://pubchem.ncbi.nlm.nih.gov/compound/Chondroitin-sulfate. Accessed 14 Aug 2020
Pulgar VM (2019) Transcytosis to cross the blood brain barrier, new advancements and challenges. Front Neurosci 13:1019. https://doi.org/10.3389/fnins.2018.01019
Purves D, Augustine GJ, Fitzpatrick D et al (2001) The retina. In: Neuroscience, 2nd edn. Sinauer Associates, Sunderland, MA
Raz A, Perouansky M (2018) Central nervous system physiology: neurophysiology. In: Pharmacology and physiology for anesthesia: foundations and clinical application. Elsevier, Amsterdam, pp 145–173
Reginster JY, Veronese N (2020) Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment. Aging Clin Exp Res 33:37–47. https://doi.org/10.1007/s40520-020-01643-8
Renjith V, Pai MS, Castelino F et al (2016) Clinical profile and functional disability of patients with migraine. J Neurosci Rural Pract 7:250–256
Rinaudo M (2006) Chitin and chitosan: properties and applications. Prog Polym Sci 31:603–632
Salem LH, El-Feky GS, Fahmy RH et al (2020) Coated lipidic nanoparticles as a new strategy for enhancing nose-to-brain delivery of a hydrophilic drug molecule. J Pharm Sci 109:2237. https://doi.org/10.1016/j.xphs.2020.04.007
Sanchez-Covarrubias L, Slosky L, Thompson B et al (2014) Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr Pharm Des 20:1422–1449
Sánchez-Dengra B, González-Álvarez I, Bermejo M, González-Álvarez M (2020) Nanomedicine in the treatment of pathologies of the central nervous system advances in nanomedicine. In: Advances in nanomedicine
Scheper V, Hoffmann A, Gepp MM et al (2019) Stem cell based drug delivery for protection of auditory neurons in a guinea pig model of cochlear implantation. Front Cell Neurosci 13:177. https://doi.org/10.3389/fncel.2019.00177
Schwieger J, Hamm A, Gepp MM et al (2020) Alginate-encapsulated brain-derived neurotrophic factor–overexpressing mesenchymal stem cells are a promising drug delivery system for protection of auditory neurons. J Tissue Eng 11:2041731420911313. https://doi.org/10.1177/2041731420911313
Serchov T, van Calker D, Biber K (2016) Sucrose preference test to measure anhedonic behaviour in mice. Bio-Protocol 6:e1958. https://doi.org/10.21769/bioprotoc.1958
Shepherd Center (n.d.) Spinal cord injury information: levels, causes, recovery. https://www.shepherd.org/patient-programs/spinal-cord-injury/about. Accessed 4 Aug 2020
Singh R, Brumlik C, Vaidya M, Choudhury A (2020) A patent review on nanotechnology-based nose-to-brain drug delivery. Recent Pat Nanotechnol 14:174. https://doi.org/10.2174/1872210514666200508121050
Sitoci-Ficici KH, Matyash M, Uckermann O et al (2018) Non-functionalized soft alginate hydrogel promotes locomotor recovery after spinal cord injury in a rat hemimyelonectomy model. Acta Neurochir 160:449–457
Snow B, Mulroy E, Bok A et al (2019) A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson’s disease. Parkinsonism Relat Disord 61:88–93
Sweeney MD, Zhao Z, Montagne A et al (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99:21–78
Teleanu DM, Negut I, Grumezescu V et al (2019) Nanomaterials for drug delivery to the central nervous system. Nanomaterials 9:371. https://doi.org/10.3390/nano9030371
Tortora GJ, Derrickson B (2011a) Chapter 12: Nervous tissue. In: Principles of anatomy and physiology, 11th edn. John Wiley and Sons, New York, NY, pp 407–442
Tortora GJ, Derrickson B (2011b) Chapter 14: The brain and cranial nerves. In: Principles of anatomy and physiology, 11th edn. John Wiley and Sons, New York, NY, pp 477–527
Tortora GJ, Derrickson B (2011c) Chapter 13: The spinal cord and spinal nerves. In: Principles of anatomy and physiology, 11th edn. John Wiley and Sons, New York, NY, pp 443–476
TRB Chemedica UK (n.d.) Structure of hyaluronan. https://vismed.trbchemedica.co.uk/business-professionals/role-and-purpose-of-hyaluronan/structure-of-hyaluronan. Accessed 14 Aug 2020
Vashist A, Atluri V, Raymond A et al (2020) Development of multifunctional biopolymeric auto-fluorescent micro- and nanogels as a platform for biomedical applications. Front Bioeng Biotechnol 8:315. https://doi.org/10.3389/fbioe.2020.00315
Vendel E, Rottschäfer V, de Lange ECM (2019) The need for mathematical modelling of spatial drug distribution within the brain. Fluids Barriers CNS 16:12
Venkatraman KL, Mehta A (2019) Health benefits and pharmacological effects of porphyra species. Plant Foods Hum Nutr 74:10–17
Violle N, Rozan P, Demais H et al (2018) Evaluation of the antidepressant- and anxiolytic-like effects of a hydrophilic extract from the green seaweed Ulva sp. in rats. Nutr Neurosci 21:248–256
Virtual Health Library (2017) Health sciences descriptors: DeCS. http://decs.bvsalud.org/I/homepagei.htm. Accessed 30 Jul 2020
Wang D, Luo M, Huang B et al (2020) Localized co-delivery of CNTF and FK506 using a thermosensitive hydrogel for retina ganglion cells protection after traumatic optic nerve injury. Drug Deliv 27:556–564
Wong AD, Ye M, Levy AF et al (2013) The blood-brain barrier: an engineering perspective. Front Neuroeng 6:7. https://doi.org/10.3389/fneng.2013.00007
World Health Organization (2013) Spinal cord injury. WHO, Geneva. https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury. Accessed 4 Aug 2020
World Health Organization (2016) Headache disorders. WHO, Geneva. https://www.who.int/news-room/fact-sheets/detail/headache-disorders. Accessed 29 Jul 2020
World Health Organization (2019a) Autism spectrum disorders. WHO, Geneva. https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders. Accessed 27 Jul 2020
World Health Organization (2019b) Epilepsy. WHO, Geneva. https://www.who.int/news-room/fact-sheets/detail/epilepsy. Accessed 19 Jun 2020
World Health Organization (2019c) Dementia. WHO, Geneva. https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed 19 Jun 2020
World Health Organization (2020) Depression. WHO, Geneva. https://www.who.int/news-room/fact-sheets/detail/depression. Accessed 28 Jul 2020
Xu Y, Zhang Q, Yu S et al (2011) The protective effects of chitooligosaccharides against glucose deprivation-induced cell apoptosis in cultured cortical neurons through activation of PI3K/Akt and MEK/ERK1/2 pathways. Brain Res 1375:49–58
Yazdi MK, Taghizadeh A, Taghizadeh M et al (2020) Agarose-based biomaterials for advanced drug delivery. J Control Release 326:523–543
Ye XC, Hao Q, Ma WJ et al (2020) Dectin-1/Syk signaling triggers neuroinflammation after ischemic stroke in mice. J Neuroinflammation 17:17. https://doi.org/10.1186/s12974-019-1693-z
Yeh WZ, Blizzard L, Taylor BV (2018) What is the actual prevalence of migraine? Brain Behav 8:e00950. https://doi.org/10.1002/brb3.950
Youssouf L, Bhaw-Luximon A, Diotel N et al (2019) Enhanced effects of curcumin encapsulated in polycaprolactone-grafted oligocarrageenan nanomicelles, a novel nanoparticle drug delivery system. Carbohydr Polym 217:35–45
Zargarzadeh M, Amaral AJR, Custódio CA, Mano JF (2020) Biomedical applications of laminarin. Carbohydr Polym 232:115774
Zayed A, Ulber R (2020) Fucoidans: downstream processes and recent applications. Mar Drugs 18:170
Zhang Q, Li N, Liu X et al (2004) The structure of a sulfated galactan from Porphyra haitanensis and its in vivo antioxidant activity. Carbohydr Res 339:105–111
Zhang L, Hao J, Zheng Y et al (2018) Fucoidan protects dopaminergic neurons by enhancing the mitochondrial function in a rotenone-induced rat model of Parkinson’s disease. Aging Dis 9:590–604
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sánchez-Dengra, B., Bermejo, M., González-Álvarez, I., González-Álvarez, M. (2022). Marine-Based Biopolymers for Central Nervous System Drug Delivery. In: Jana, S., Jana, S. (eds) Marine Biomaterials . Springer, Singapore. https://doi.org/10.1007/978-981-16-4787-1_10
Download citation
DOI: https://doi.org/10.1007/978-981-16-4787-1_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-4786-4
Online ISBN: 978-981-16-4787-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)